Aevi Genomic Medicine
2000
FOUNDED
PUBLIC
STATUS
11-20
EMPLOYEES
GNMX
STOCK SYMBOL
1
INVESTMENTS
$0.15
SHARE PRICE
(As of Wednesday Closing)
Description
Medgenics is a clinical-stage biopharmaceutical company involved mainly in genomic medicine. Genomic medicine involves the usage of individual's genomic information to decide upon clinical care. This medical discipline is used in the fields of oncology, pharmacology, rare and undiagnosed diseases, and infectious diseases. Medgenics' partner is the Center for Applied Genomics at the Children's Hospital of Philadelphia, with which it works to develop drugs by implementing genomics medicine.
Website
Formerly Known As
Biogenics, MedGenics
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
NAS
Primary Office
- 435 Devon Park Drive
- Suite 715
- Wayne, PA 19087
- United States
+1 (610) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Aevi Genomic Medicine’s full profile, request a free trial.
Aevi Genomic Medicine Stock Performance
| 52 wk Range | Market Cap | Prev. Close | EPS | Average Volume | Shares |
|---|---|---|---|---|---|
| $0.11 - $1.23 | $9.5M | $0.16 | -$0.29 | 729K | 64.8M |
Aevi Genomic Medicine Financials Summary
|
In Thousands,
USD |
TTM
30-Sep-2019
|
FY 2018
31-Dec-2018
|
FY 2017
31-Dec-2017
|
FY 2016
31-Dec-2016
|
|---|---|---|---|---|
| Enterprise Value | 6,278 | 25,735 | 56,239 | 144,910 |
| Revenue | 0 | 0 | 0 | 0 |
| EBITDA | (19,206) | (30,916) | (34,621) | (41,615) |
| Net Income | (19,152) | (30,775) | (34,714) | (41,904) |
| Total Assets | 2,796 | 12,277 | 34,761 | 40,561 |
| Total Debt | 0 | 0 | 0 | 0 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Aevi Genomic Medicine Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Aevi Genomic Medicine‘s full profile, request access.
Request full access to PitchBookAevi Genomic Medicine Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
This information is reserved for PitchBook Platform users. To explore Aevi Genomic Medicine‘s full profile, request access.
Request full access to PitchBookAevi Genomic Medicine Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00000000 000000000 | 09-Sep-2015 | 000000000000000000 | 00000 | Drug Discovery | 0000000 0000 |
Aevi Genomic Medicine Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore Aevi Genomic Medicine‘s full profile, request access.
Request full access to PitchBookAevi Genomic Medicine Executive Team (10)
6 Former Executives
You’re viewing 4 of 10 executives. Get the full list »Aevi Genomic Medicine Board Members (11)
6 Former Board Members
You’re viewing 5 of 11 board members. Get the full list »